- Home
- OTLK vs GAIA Comparison
OTLK vs GAIA Comparison
Compare OTLK & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OTLK | GAIA |
|---|---|---|
| Founded | 2010 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.8M | 105.7M |
| IPO Year | 2016 | 1999 |
Fundamental Metrics
Financial Performance| Metric | OTLK | GAIA |
|---|---|---|
| Price | $2.18 | $3.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $4.00 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 3.4M | 107.9K |
| Earning Date | 12-24-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,505,322.00 | ★ $98,622,000.00 |
| Revenue This Year | N/A | $11.55 |
| Revenue Next Year | $342.80 | $11.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.80 |
| 52 Week Low | $0.79 | $2.93 |
| 52 Week High | $3.39 | $6.39 |
Technical Indicators
Market Signals| Indicator | OTLK | GAIA |
|---|---|---|
| Relative Strength Index (RSI) | 67.60 | 48.05 |
| Support Level | $1.91 | $3.65 |
| Resistance Level | $2.10 | $4.09 |
| Average True Range (ATR) | 0.15 | 0.25 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 95.65 | 84.95 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About GAIA Gaia Inc.
Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.